Adaptive Biotech (@AdaptiveBiotech) / X
Adaptive Biotechnologies - Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer
Morgan Stanley Maintains Adaptive Biotechnologies (ADPT) Equal-Weight Recommendation
Microsoft invests in Adaptive Biotechnologies to develop blood test to detect diseases | The Seattle Times
Adaptive Biotechnologies Corp. | LinkedIn
Who We Are - Adaptive Biotech
Adaptive Biotechnologies eyes expansion to Europe - Puget Sound Business Journal
Covid-19 : Amgen et Adaptive Biotechnologies vont développer des anticorps
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access - Stories
Adaptive Biotechnologies will triple size of its Seattle HQ following IPO – GeekWire
Adaptive Biotechnologies Announces Acquisition Of Sequenta, Inc.
Adaptive Leadership - Adaptive Biotech
Adaptive Biotechnologies - Headquarters and Laboratory | Flad Architects
Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease | Business Wire
Career Listings - Adaptive Biotech
Adaptive Biotechnologies signs deal with Genentech for personalized cancer treatments worth up to $2 billion
Adaptive Biotechnologies Is Developing a New Test to Identify COVID-19 Immunity | Built In Seattle
Microsoft Customer Story-Adaptive Biotechnologies transforms data stream into new immune medicine platform with Azure
DDD Partners LLC Takes $4.27 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Office & Laboratory Tenant Improvement - EwingCole
Adaptive Biotechnologies | Flad Architects | Archello
Alexandria Real Estate Equities, Inc. Celebrates Grand Opening of Adaptive Biotechnologies' New State-of-the-Art Waterfront Headquarters/R&D Facility at 1165 Eastlake in the Thriving Seattle Life Science Cluster
Adaptive Biotechnologies Corp. | LinkedIn
